. Le-dosage-des-marqueurs-tumoraux, PSA) doit être fait mais c'est surtout l'imagerie qui permettra d'orienter le clinicien. Une endoscopie digestive, un examen ORL avec nasofibroscopie, un examen gynécologique avec mammographie et frotti cervico-vaginal chez la femme peuvent être proposés

M. Horellou, C. Flaujac, G. Thibault, and I. , Hémostase : physiologie et principaux test d'exploration. EMC -Traité Médecine AKOS, pp.1-4, 2012.
DOI : 10.1016/s1634-6939(06)75175-4

S. Butenas, T. Orfeo, K. Brummel-ziedins, and K. Mann, Tissue factor in thrombosis and hemorrhage, Surgery, vol.142, issue.4, pp.2-14, 2007.
DOI : 10.1016/j.surg.2007.06.032

A. Lebreton and G. Lavigne, Les anticorps anti-FVIII et anti-FIX. Rev Fr Lab, pp.55-62, 2012.
DOI : 10.1016/s1773-035x(12)71502-2

K. Mann, K. Brummel-ziedins, T. Orfeo, and S. Butenas, Models of blood coagulation, Blood Cells, Molecules, and Diseases, vol.36, issue.2, pp.108-125, 2006.
DOI : 10.1016/j.bcmd.2005.12.034

M. Samama and C. Emile, Hémostase et thrombose. Cahier de Formation Biologie médicale, 2000.

M. Cugno, R. Gualtierotti, A. Tedeschi, and P. Meroni, Autoantibodies to coagulation factors: From pathophysiology to diagnosis and therapy, Autoimmunity Reviews, vol.13, issue.1, pp.40-48, 2014.
DOI : 10.1016/j.autrev.2013.08.001

M. Aillaud, Facteur VIII????: antih??mophilique A, EMC - Biologie M??dicale, vol.1, issue.1, pp.90-110, 2007.
DOI : 10.1016/S2211-9698(06)76157-X

P. Lollar, Pathogenic antibodies to coagulation factors. Part one: Factor VIII and Factor IX, Journal of Thrombosis and Haemostasis, vol.111, issue.Suppl. 1, pp.1082-95, 2004.
DOI : 10.1172/JCI200316887

P. Collins and C. Percy, Advances in the understanding of acquired haemophilia A: implications for clinical practice, British Journal of Haematology, vol.105, issue.Suppl. 10, pp.183-94, 2010.
DOI : 10.4049/jimmunol.180.11.7714

A. Aouba, G. Rey, G. Pavillon, E. Jougla, C. Rothschild et al., Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategies, Haemophilia, vol.153, issue.3, pp.339-383, 2012.
DOI : 10.1111/j.1365-2141.2010.08517.x

M. Mazzucconi, M. Peraino, L. Bizzoni, S. Bernasconi, M. Luciani et al., Acquired inhibitor against factor IX in a child: successful treatment with high-dose immunoglobulin and dexamethasone, Haemophilia, vol.93, issue.2, pp.132-136, 1999.
DOI : 10.1046/j.1365-2516.1999.t01-1-00297.x

P. Krishnamurthy, C. Hawche, G. Evans, and M. Winter, A rare case of an acquired inhibitor to factor IX, Haemophilia, vol.138, issue.4, pp.712-715, 2011.
DOI : 10.1111/j.1365-2141.2007.06657.x

A. Federici, U. Budde, and J. Rand, Acquired von Willebrand syndrome 2004: International Registry-diagnosis and management from online to bedside, Hämostaseologie, vol.24, pp.50-55, 2004.

S. Kumar, R. Pruthi, and W. Nichols, Acquired von Willebrand's syndrome: A single institution experience, American Journal of Hematology, vol.5, issue.4, pp.243-250, 2003.
DOI : 10.1089/thy.1995.5.399

URL : http://onlinelibrary.wiley.com/doi/10.1002/ajh.10298/pdf

A. Bezeaud and M. Guillin, Exploration de la coagulation, EMC - H??matologie, vol.1, issue.1, 2001.
DOI : 10.1016/S1155-1984(06)74772-0

P. Collins, F. Baudo, A. Huth-kühne, J. Ingerslev, C. Kessler et al., Consensus recommendations for the diagnosis and treatment of acquired hemophilia A, BMC Research Notes, vol.3, issue.1, pp.161-169, 2010.
DOI : 10.1186/1756-0500-3-161

H. Lévesque, J. Borg, P. Bossi, J. Goudemand, B. Guillet et al., L??h??mophilie acquise??: approches diagnostiques et th??rapeutiques actuelles, approches diagnostiques et thérapeutiques actuelles, pp.854-66, 2001.
DOI : 10.1016/S0248-8663(01)00436-2

A. Morrison, C. Ludlam, and C. Kessler, Use of porcine factor VIII in the treatment of patients with acquired hemophilia, Blood, vol.81, pp.1513-1533, 1993.

A. Pavlova, A. Diaz-lacava, H. Zeitler, J. Satoguina, B. Niemann et al., Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls, Haemophilia, vol.174, issue.12, pp.355-60, 2008.
DOI : 10.4049/jimmunol.174.9.5181

M. Ling, E. Duncan, S. Rodgers, A. Somogyi, G. Crabb et al., Classification of the kinetics of factor VIII inhibitors in haemophilia A: plasma dilution studies are more discriminatory than time-course studies, British Journal of Haematology, vol.73, issue.4, pp.861-868, 2001.
DOI : 10.1046/j.1365-2516.1998.440543.x

T. Matsumoto, K. Nogami, K. Ogiwara, and M. Shima, A putative inhibitory mechanism in the tenase complex responsible for loss of coagulation function in acquired haemophilia A patients with anti-C2 autoantibodies, Thrombosis and Haemostasis, vol.107, issue.2, pp.288-301, 2012.
DOI : 10.1160/TH11-05-0331

S. Shetty, M. Bhave, and K. Ghosh, Acquired hemophilia A: Diagnosis, aetiology, clinical spectrum and treatment options, Autoimmunity Reviews, vol.10, issue.6, pp.311-317, 2011.
DOI : 10.1016/j.autrev.2010.11.005

J. Delgado, V. Jimenez-yuste, F. Hernandez-navarro, and A. Villar, Acquired Haemophilia: Review and Meta-Analysis Focused on Therapy and Prognostic Factors, British Journal of Haematology, vol.60, issue.1, pp.21-35, 2003.
DOI : 10.1046/j.1365-2257.2000.00316.x

URL : http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2141.2003.04162.x/pdf

P. Knoebl, P. Marco, F. Baudo, P. Collins, A. Huth-kühne et al., Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2), Journal of Thrombosis and Haemostasis, vol.110, issue.Suppl 1, pp.622-653, 2012.
DOI : 10.7326/0003-4819-110-10-774

R. Lottenberg, T. Kentro, and C. Kitchens, Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy, Archives of Internal Medicine, vol.147, issue.6, pp.1077-81, 1987.
DOI : 10.1001/archinte.147.6.1077

C. Hay, S. Brown, P. Collins, D. Keeling, and R. Liesner, The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation, British Journal of Haematology, vol.35, issue.2, pp.591-605, 2006.
DOI : 10.1182/blood-2004-05-1811

D. Sborov and G. Rodgers, How I manage patients with acquired haemophilia A, British Journal of Haematology, vol.39, issue.Suppl. 2, pp.157-65, 2013.
DOI : 10.1159/000341913

URL : http://onlinelibrary.wiley.com/doi/10.1111/bjh.12228/pdf

J. Spero, J. Lewis, and U. Hasiba, Corticosteroid Therapy for Acquired F VIII:C Inhibitors, British Journal of Haematology, vol.43, issue.4, pp.635-677, 1981.
DOI : 10.1111/j.1365-2141.1981.00635.x

A. Huth-kühne, F. Baudo, P. Collins, J. Ingerslev, C. Kessler et al., International recommendations on the diagnosis and treatment of patients with acquired hemophilia A, Haematologica, vol.94, issue.4, pp.566-75, 2009.
DOI : 10.3324/haematol.2008.001743

P. Collins, S. Hirsch, T. Baglin, G. Dolan, J. Hanley et al., Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation, Blood, vol.109, issue.5, pp.1870-1877, 2007.
DOI : 10.1182/blood-2006-06-029850

D. Green and K. Lechner, A survey of 215 non-hemophilic patients with inhibitors to Factor VIII, Thromb Haemost, vol.45, pp.200-203, 1981.

F. Girelli, C. Biasoli, B. Bassi, F. Bagioni, G. Bondi et al., Efficacy of Corticosteroids Alone in the Eradication of Factor VIII Inhibitor in an Old Female with Idiopathic Acquired Haemophilia A: Description of a Case, Case Reports in Rheumatology, vol.63, issue.2, p.3, 2012.
DOI : 10.1055/s-0029-1245109

A. Stepanian and C. Biron-andréani, Exploration de l'hémostase primaire, Ann Biol Clin (Paris), vol.59, pp.725-760, 2001.

M. Horellou, J. Conard, and M. Samama, Allongement du temps de c??phaline + activateur, EMC - Trait?? de m??decine AKOS, vol.1, issue.1, pp.1-1175, 2001.
DOI : 10.1016/S1634-6939(06)75177-8

M. Horellou, J. Conard, and M. Samama, Allongement du temps de Quick, EMC - Trait?? de m??decine AKOS, vol.1, issue.1, pp.1-1185, 2001.
DOI : 10.1016/S1634-6939(06)75178-X

B. Verbruggen, W. Van-heerde, and B. Laros-van-gorkom, Improvements in Factor VIII Inhibitor Detection: From Bethesda to Nijmegen, Seminars in Thrombosis and Hemostasis, vol.35, issue.08, pp.752-761, 2009.
DOI : 10.1055/s-0029-1245107

C. Kasper, L. Aledort, D. Aronson, R. Counts, J. Edson et al., Proceedings: A more uniform measurement of factor VIII inhibitors, Thromb Diath Haemorrh, vol.34, p.612, 1975.

B. Verbruggen, I. Novakova, H. Wessels, J. Boezeman, M. Van-den-berg et al., The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability, Thromb Haemost, vol.73, pp.247-51, 1995.

B. Wootla, S. Dasgupta, J. Dimitrov, J. Bayry, H. Lévesque et al., Factor VIII Hydrolysis Mediated by Anti-Factor VIII Autoantibodies in Acquired Hemophilia, The Journal of Immunology, vol.180, issue.11, pp.7714-7734, 2008.
DOI : 10.4049/jimmunol.180.11.7714

URL : http://www.jimmunol.org/content/jimmunol/180/11/7714.full.pdf

J. Krudysz-amblo, B. Parhami-seren, S. Butenas, K. Brummel-ziedins, E. Gomperts et al., Quantitation of anti-factor VIII antibodies in human plasma, Blood, vol.113, issue.11, pp.2587-94, 2009.
DOI : 10.1182/blood-2008-08-174987

L. Federici, M. Hue, J. Barats, G. Blaison, I. Mazurier et al., H??mophilie acquise et anticorps ????non inhibiteur???? anti-facteur??VIII, La Revue de M??decine Interne, vol.30, p.420, 2009.
DOI : 10.1016/j.revmed.2009.10.264

F. Baudo, P. Collins, A. Huth-kühne, H. Lévesque, P. Marco et al., Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry, Blood, vol.120, issue.1, pp.39-46, 2012.
DOI : 10.1182/blood-2012-02-408930

C. Hay, 1 Acquired haemophilia, Bailli??re's Clinical Haematology, vol.11, issue.2, pp.287-303, 1998.
DOI : 10.1016/S0950-3536(98)80049-8

L. Tay, E. Duncan, D. Singhal, R. Al-qunfoidi, D. Coghlan et al., Twelve Years of Experience of Acquired Hemophilia A: Trials and Tribulations in South Australia, Seminars in Thrombosis and Hemostasis, vol.35, issue.08, pp.769-77, 2010.
DOI : 10.1055/s-0029-1245109

S. Sahu, R. Raipancholia, F. Pardiwalla, and A. Pathare, Hemostasis in acquired hemophilia--role of intracavitary instillation of EACA, J Postgrad Med, vol.42, pp.88-90, 1996.

S. Sallah, Treatment of acquired haemophilia with factor eight inhibitor bypassing activity, Haemophilia, vol.48, issue.2, pp.169-73, 2004.
DOI : 10.1046/j.1365-2516.2002.00532.x

L. Aledort, Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity, Journal of Thrombosis and Haemostasis, vol.8, issue.10, pp.1700-1708, 2004.
DOI : 10.1046/j.1365-2516.1998.440564.x

C. Hay, C. Negrier, and C. Ludlam, The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study, Thromb Haemost, vol.78, pp.1463-1470, 1997.

M. Sumner, B. Geldziler, M. Pedersen, and S. Seremetis, Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal, Haemophilia, vol.24, issue.5, pp.451-61, 2007.
DOI : 10.1007/s002770100367

M. Franchini and G. Lippi, The use of desmopressin in acquired haemophilia A: a systematic review, Blood Transfus, vol.9, pp.377-82, 2011.

M. Jansen, S. Schmaldienst, S. Banyai, P. Quehenberger, I. Pabinger et al., Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb), British Journal of Haematology, vol.36, issue.1, pp.91-98, 2001.
DOI : 10.1007/s002770050108

C. Négrier, M. Dechavanne, F. Alfonsi, and P. Tremisi, Successful Treatment of Acquired Factor VIII Antibody by Extracorporeal Immunoadsorption, Acta Haematologica, vol.85, issue.2, pp.107-117, 1991.
DOI : 10.1159/000204868

J. Astermark, S. Donfield, D. Dimichele, A. Gringeri, S. Gilbert et al., A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study, Blood, vol.109, issue.2, pp.546-51, 2007.
DOI : 10.1182/blood-2006-04-017988

M. Franchini and P. Mannucci, Acquired haemophilia A: A 2013 update, Thrombosis and Haemostasis, vol.110, issue.6, pp.1114-1134, 2013.
DOI : 10.1160/TH13-05-0363

URL : https://www.schattauer.de/index.php?id=5236&mid=20195

D. Green, A. Rademaker, and E. Briët, A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies, Thromb Haemost, vol.70, pp.753-760, 1993.

W. Sperr, K. Lechner, and I. Pabinger, Rituximab for the treatment of acquired antibodies to factor VIII, Haematologica, vol.92, issue.1, pp.66-71, 2007.
DOI : 10.3324/haematol.10553

P. Collins, M. Mathias, J. Hanley, D. Keeling, R. Keenan et al., Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort, Journal of Thrombosis and Haemostasis, vol.13, issue.Suppl. 1, pp.787-94, 2009.
DOI : 10.1111/j.1538-7836.2009.03332.x

P. Collins, Therapeutic challenges in acquired factor VIII deficiency. Hematol Educ Program Am Soc Hematol Am Soc Hematol Educ Program, pp.369-74, 2012.

Y. Sultan, M. Kazatchkine, P. Maisonneuve, and U. Nydegger, ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN, The Lancet, vol.324, issue.8406, pp.765-773, 1984.
DOI : 10.1016/S0140-6736(84)90701-3

R. Schwartz, D. Gabriel, L. Aledort, D. Green, and C. Kessler, A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin, Blood, vol.86, pp.797-804, 1995.

I. Marie, G. Maurey, F. Hervé, M. Hellot, and H. Levesque, Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature, British Journal of Dermatology, vol.46, issue.4, pp.714-735, 2006.
DOI : 10.1212/WNL.46.1.250

L. Nemes and E. Pitlik, New protocol for immune tolerance induction in acquired hemophilia, Haematologica, vol.85, pp.64-72, 2000.

H. Zeitler, G. Ulrich-merzenich, L. Hess, E. Konsek, C. Unkrig et al., Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept, Blood, vol.105, issue.6, pp.2287-93, 2005.
DOI : 10.1182/blood-2004-05-1811

H. Zeitler, G. Ulrich-merzenich, G. Goldmann, N. Vidovic, H. Brackmann et al., The relevance of the bleeding severity in the treatment of acquired haemophilia - an update of a single-centre experience with 67 patients, Haemophilia, vol.5, issue.102, pp.95-101, 2010.
DOI : 10.1111/j.1365-2516.2008.01922.x

M. Merlini, F. Moccia, M. Delucchi, and G. Grillo, Severe bleeding in a case of acquired factor VIII inhibitor associated with generalized pustular psoriasis, pp.248-52, 2005.

A. Soria, E. Matichard, V. Descamps, and B. Crickx, Pemphigo??de et h??mophilie acquise, Annales de Dermatologie et de V??n??r??ologie, vol.134, issue.4, pp.353-359, 2007.
DOI : 10.1016/S0151-9638(07)89190-3

A. Soria, E. Matichard, E. Maubec, S. Bouvresse, V. Descamps et al., P111 - H??mophilie acquise au cours d???une pemphigo??de, Annales de Dermatologie et de V??n??r??ologie, vol.132, p.9137, 2005.
DOI : 10.1016/S0151-9638(05)79840-9

N. Kluger, R. Navarro, V. Pallure, N. Kluger, B. Navarro et al., Pemphigo??de bulleuse et h??mophilie acquise, Annales de Dermatologie et de V??n??r??ologie, vol.138, issue.5, pp.422-425, 2011.
DOI : 10.1016/j.annder.2011.01.040

E. Lightburn, J. Morand, B. Graffin, S. Molinier, G. Raphenon et al., Pemphigoïde et hémophilie acquise, Ann Dermatol Vénéréologie, vol.128, pp.1229-1260, 2001.

M. Aljasser, C. Sladden, R. Crawford, and S. Au, Bullous Pemphigoid Associated with Acquired Hemophilia A: A Rare Association of Autoimmune Disease, Journal of Cutaneous Medicine and Surgery, vol.73, issue.2, pp.123-129, 2014.
DOI : 10.3324/haematol.2008.001743

L. Thi-huong, D. Guillevin, L. Borg, J. Besancenot, J. et al., Anticoagulants circulants en dehors de l'hémophilie. Enquête conduite par le secrétariat à la recherche de la SNFMI à propos de 207 observations. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.33-42, 1988.

O. Arakaki, Y. Yamamoto, R. Awazawa, K. Nonaka, K. Taira et al., Case of linear immunoglobulin A bullous dermatosis associated with acquired hemophilia, The Journal of Dermatology, vol.103, issue.7, pp.437-483, 2008.
DOI : 10.1182/asheducation-2006.1.432

S. Kornfeld, C. Veyssier-belot, A. Vinceneux, J. Renier, L. Du-boutin et al., Hémophilie acquise au cours d'un lupus érythémateux systémique, Ann Dermatol Vénéréologie, vol.129, pp.316-325, 2002.

A. Drobiecki, M. Pasiarski, I. Hus, B. Soko?owska, and M. W?tek, Acquired hemophilia in the patient suffering from rheumatoid arthritis, Blood Coagulation & Fibrinolysis, vol.24, issue.8, pp.874-80, 2013.
DOI : 10.1097/MBC.0b013e3283646635

M. Gallant, R. Lories, and J. Verbanck, Polymyalgia rheumatica/arteritis temporalis and acquired factor VIII inhibitor, Clinical Rheumatology, vol.133, issue.S1, pp.19-21, 2008.
DOI : 10.1007/s10067-007-0817-5

M. Vintimilla, A. Joseph, and P. Ranganathan, Acquired factor VIII inhibitor in Sj??gren's syndrome, Arthritis Care & Research, vol.13, issue.7, pp.1047-50, 2010.
DOI : 10.7326/0003-4819-110-10-774

K. Norrby and B. Ridell, Tumour-type-specific capillary endothelial cell stainability in malignant B-cell lymphomas using antibodies against CD31, CD34 and Factor VIII, APMIS, vol.45, issue.4, pp.483-492, 2003.
DOI : 10.1136/jcp.45.2.143

A. Mahipal and S. Bilgrami, Acquired hemophilia in chronic lymphocytic leukemia, Leukemia & Lymphoma, vol.10, issue.5, pp.1026-1034, 2007.
DOI : 10.1182/blood-2002-03-0765

D. Green, Spontaneous inhibitors to coagulation factors, Clinical and Laboratory Haematology, vol.73, issue.s1, pp.21-26, 2000.
DOI : 10.1046/j.1365-2257.2000.00001.x

S. Davidson, J. Burman, A. Nicholson, D. Jones, and M. Dusmet, Factor XII auto-antibodies present in a patient with a B-cell lymphoma, Blood Coagulation & Fibrinolysis, vol.16, issue.5, pp.365-372, 2005.
DOI : 10.1097/01.mbc.0000173466.53236.52

E. Lian, A. Larcada, and A. Chiu, Combination Immunosuppressive Therapy after Factor VIII Infusion for Acquired Factor VIII Inhibitor, Annals of Internal Medicine, vol.110, issue.10, pp.774-782, 1989.
DOI : 10.7326/0003-4819-110-10-774

M. Raval, R. Kallamadi, and D. Bande, A rare case of acquired hemophilia A associated with myelodysplastic syndrome, Int J Clin Exp Med, vol.5, pp.262-268, 2012.

S. Sallah and J. Wan, Inhibitors against factor VIII in patients with cancer, Cancer, vol.82, issue.6, pp.1067-74, 2001.
DOI : 10.1097/00000421-199908000-00019

A. Ferre, J. Arlet, L. Darnige, S. Dupeux, and J. Pouchot, H??mophilie A acquise pr??c??dant l???apparition d???un cancer??: quelles explorations et quelle surveillance???, La Revue de M??decine Interne, vol.30, issue.7, pp.630-633, 2009.
DOI : 10.1016/j.revmed.2008.09.001

M. Haj, H. Dasani, S. Kundu, U. Mohite, and P. Collins, Acquired haemophilia A may be associated with clopidogrel, BMJ, vol.329, issue.7461, p.323, 2004.
DOI : 10.1136/bmj.329.7461.323

URL : http://www.bmj.com/content/bmj/329/7461/323.1.full.pdf

J. Goyal, P. Tyagi, and N. Kumar, Acquired haemophilia in a patient treated with interferon-?? for hepatitis C infection, Haemophilia, vol.121, issue.3, pp.73-77, 2012.
DOI : 10.1046/j.1365-2141.2003.04162.x

J. Delyon, C. Mateus, T. Lambert, and C. Robert, Une h??mophilie acquise ?? l???ipilimumab, Annales de Dermatologie et de V??n??r??ologie, vol.138, issue.12, p.278, 2011.
DOI : 10.1016/j.annder.2011.10.364

L. Tengborn, F. Baudo, A. Huth-kühne, P. Knoebl, H. Lévesque et al., Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry, BJOG: An International Journal of Obstetrics & Gynaecology, vol.120, issue.Suppl 12, pp.1529-1566, 2012.
DOI : 10.1182/blood-2012-02-409185

L. Mata, M. Costecalde, J. François, L. Carpentier, and E. Wiel, Auto-anticorps anti-facteur VIII et infection ?? Chlamydia pneumoniae, Annales Fran??aises d'Anesth??sie et de R??animation, vol.21, issue.7, pp.606-615, 2002.
DOI : 10.1016/S0750-7658(02)00686-X

P. Bossi, J. Cabane, J. Ninet, R. Dhote, T. Hanslik et al., Acquired hemophilia due to factor VIII inhibitors in 34 patients, The American Journal of Medicine, vol.105, issue.5, pp.400-408, 1998.
DOI : 10.1016/S0002-9343(98)00289-7

F. Baudo and F. De-cataldo, Acquired hemophilia: a critical bleeding syndrome, Haematologica, vol.89, pp.96-100, 2004.

J. Borg, B. Guillet, L. Cam-duchez, V. Goudemand, J. Lévesque et al., Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hémophilie Acquise) registry. Haemoph Off J World Fed Hemoph, pp.564-70, 2013.

E. Estève, P. Armingaud, and L. Martin, H??matomes cutan??s et sous-cutan??s vus en dermatologie : 17 cas, Annales de Dermatologie et de V??n??r??ologie, vol.131, issue.6-7, pp.555-563, 2004.
DOI : 10.1016/S0151-9638(04)93667-8

A. Nelva, C. Guy, B. Tardy-poncet, M. Beyens, M. Ratrema et al., Syndromes h??morragiques sous antid??presseurs inhibiteurs s??lectifs de la recapture de la s??rotonine (ISRS). ?? propos de sept cas et revue de la litt??rature, La Revue de M??decine Interne, vol.21, issue.2, pp.152-60, 2000.
DOI : 10.1016/S0248-8663(00)88244-2

E. Clyti, H. Théophile, J. Klisnik, A. Daveluy, D. Sainte-marie et al., Parox??tine (Deroxat??) et ecchymoses, Annales de Dermatologie et de V??n??r??ologie, vol.133, issue.12, pp.1011-1013, 2006.
DOI : 10.1016/S0151-9638(06)71091-2

O. Fain, Carences en vitamine C. Rev Médecine Interne, pp.872-80, 2004.
DOI : 10.1016/j.revmed.2004.03.009

S. Hercberg, P. Preziosi, P. Galan, M. Deheeger, L. Papoz et al., Apports nutritionnels d'un échantillon représentatif de la population du Val de Marne, Rev Dépidémiologie Santé Publique, vol.39, pp.245-61, 1991.

K. Mckenna and J. Dawson, Scurvy occurring in a teenager, Clinical and Experimental Dermatology, vol.22, issue.1, pp.75-82, 1993.
DOI : 10.1079/PNS19730046

M. Shearer, X. Fu, and S. Booth, Vitamin K Nutrition, Metabolism, and Requirements: Current Concepts and Future Research, Advances in Nutrition, vol.53, issue.Suppl 1, pp.182-95, 2012.
DOI : 10.3177/jnsv.53.464

URL : http://advances.nutrition.org/content/3/2/182.full.pdf

P. Boussault, M. Doutre, M. Beylot-barry, J. Constans, C. Conri et al., Syndrome des ecchymoses douloureuses, une maladie psychogène. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.744-751, 2005.
DOI : 10.1016/j.revmed.2005.05.013

O. Ivanov, A. Lvov, A. Michenko, J. Künzel, P. Mayser et al., Autoerythrocyte sensitization syndrome (Gardner-Diamond syndrome): review of the literature**, Journal of the European Academy of Dermatology and Venereology, vol.250, issue.Suppl. 1, pp.499-504, 2009.
DOI : 10.7326/0003-4819-70-6-1201

P. Beighton, D. Paepe, A. Steinmann, B. Tsipouras, P. Wenstrup et al., Ehlers-Danlos syndromes: Revised nosology, Villefranche, 1997, American Journal of Medical Genetics, vol.33, issue.1, pp.31-38, 1998.
DOI : 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O

M. Franchini, F. Capra, N. Nicolini, D. Veneri, F. Manzato et al., Drug-Induced Antifactor VIII Antibodies, ChemInform, vol.13, issue.45, pp.55-61, 2007.
DOI : 10.1002/chin.200745229

O. Reilly, R. Hamilton, and R. , Acquired hemophilia, meningioma, and diphenylhydantoin therapy, Journal of Neurosurgery, vol.91, issue.5, pp.600-605, 1980.
DOI : 10.7326/0003-4819-91-2-194

E. Castenskiold, B. Colvin, and S. Kelsey, Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy in a patient with haemophilia A, British Journal of Haematology, vol.115, issue.2, pp.434-440, 1994.
DOI : 10.1016/0090-1229(92)90250-R

R. Stricker, B. Barlogie, and D. Kiprov, Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy, J Rheumatol, vol.21, pp.350-352, 1994.

K. English, W. Brien, K. Howson-jan, and M. Kovacs, Acquired Factor VIII Inhibitor in a Patient with Chronic Myelogenous Leukemia Receiving Interferon-Alfa Therapy, Annals of Pharmacotherapy, vol.13, issue.6, pp.737-746, 2000.
DOI : 10.1038/clpt.1981.154

S. Regina, P. Colombat, B. Fimbel, C. Guerois, and Y. Gruel, Acquired inhibitor to factor VIII in a patient with Hodgkin's disease following treatment with interferon-alpha, Haemophilia, vol.16, issue.5, pp.526-533, 2001.
DOI : 10.3109/10428199509054441

G. Ferri, F. Vaccaro, D. Caccavo, G. Imperato, and L. Bonomo, Development of Factor Vlll:C Inhibitors Following Vaccination, Acta Haematologica, vol.96, issue.2, pp.110-111, 1996.
DOI : 10.1159/000203727

A. Stewart, L. Manson, H. Dasani, A. Beddall, P. Collins et al., Acquired haemophilia in recipients of depot thioxanthenes, Haemophilia, vol.3, issue.6, pp.709-721, 2000.
DOI : 10.1080/10245332.1998.11746390

P. Collins, N. Macartney, R. Davies, S. Lees, J. Giddings et al., A population based, unselected, consecutive cohort of patients with acquired haemophilia A, British Journal of Haematology, vol.48, issue.1, pp.86-90, 2004.
DOI : 10.1046/j.1365-2257.2000.00316.x

S. Sallah and J. Wan, Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine, Thromb Haemost, vol.86, pp.1119-1140, 2001.

C. Tiplady, P. Hamilton, and M. Galloway, Acquired haemophilia complicating the remission of a patient with high grade non-Hodgkin's lymphoma treated by fludarabine, Clinical and Laboratory Haematology, vol.47, issue.3, pp.163-168, 2000.
DOI : 10.1002/1097-0142(19810615)47:12<2901::AID-CNCR2820471226>3.0.CO;2-H

Y. Huang, P. Saidi, and C. Philipp, Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases, Haemophilia, vol.16, issue.5, pp.713-734, 2004.
DOI : 10.1016/S0140-6736(84)92764-8

G. Famularo, D. Maria, S. Minisola, G. Nicotra, and G. , Severe Acquired Hemophilia with Factor VIII Inhibition Associated with Acetaminophen and Chlorpheniramine, Annals of Pharmacotherapy, vol.124, issue.9, pp.1432-1436, 2004.
DOI : 10.1046/j.1365-2516.2002.00532.x

F. Capra, N. Nicolini, and M. Franchini, Is the periodic repetition of a coagulation check necessary during anti-hepatitis C virus therapy?, Gut, vol.55, issue.6, p.902, 2006.
DOI : 10.1136/gut.2006.091496

Z. Schreiber and N. Bräu, Acquired factor VIII inhibitor in patients with hepatitis C virus infection and the role of interferon-??: A case report, American Journal of Hematology, vol.25, issue.4, pp.295-303, 2005.
DOI : 10.1002/ajh.20405

C. Herman, L. Boggio, and D. Green, Factor VIII inhibitor associated with peginterferon, Haemophilia, vol.103, issue.4, pp.408-418, 2005.
DOI : 10.7326/0003-4819-125-4-199608150-00007

B. Reeves and N. Key, Acquired hemophilia in malignancy, Thrombosis Research, vol.129, pp.66-74, 2012.
DOI : 10.1016/S0049-3848(12)70019-1

G. Krieger, J. Wuchter, J. Stockinger, and J. Schirmeister, Spontane Auftreten eines Faktor VIII- Inhibitor in Glomerulonephritis und Immunoglobulin A-Mangel, Schweiz Med Wochenschr, vol.113, pp.976-80, 1983.